BTS Clinical Statement on air travel for passengers with respiratory ...



idiopathic primary pulmonary hypertension :: Article Creator

Severe Pulmonary Hypertension: What To Know

When the mean blood pressure in the pulmonary arteries is over 70 millimeters of mercury (mmHg), someone has severe pulmonary hypertension. Without prompt medical intervention, it can lead to heart and lung dysfunction.

Individuals with pulmonary hypertension may notice shortness of breath, chest pain, intense fatigue, and severe dizziness. However, these symptoms could worsen when the disease progresses to severe pulmonary arterial hypertension.

Early diagnosis and treatment are critical to improving the outlook for someone with severe pulmonary hypertension.

This article discusses severe pulmonary hypertension, its causes, stages, and treatment options.

Doctors define pulmonary hypertension as an elevated blood pressure in the pulmonary arteries. Typically, a doctor will diagnose pulmonary hypertension when a person's average systolic arterial pressure reaches 35 mmHg or higher. The systolic pressure is the pressure in your arteries when your heart beats.

Other clinical symptoms may appear too.

Pulmonary hypertension is a progressive disorder. Without prompt intervention, it can gradually worsen and become severe.

Severe pulmonary hypertension occurs when the mean resting blood pressure in the pulmonary arteries is above 70 mmHg. Severe pulmonary hypertension is rare but may occur in people with chronic medical disorders, such as chronic obstructive pulmonary disease (COPD).

Learn more about COPD and high blood pressure.

Severe pulmonary hypertension has associations with increased vascular resistance, a condition that can result in right-sided heart failure. Reduced blood supply and the heart working harder are likely the reasons for the heart failure.

Consequently, individuals with severe pulmonary hypertension may present with any of the following symptoms:

Severe pulmonary hypertension is life threatening, so a person with these symptoms should seek urgent medical attention.

Learn more about symptoms, causes, and diagnosis of PAH.

Several factors, such as genetics, environmental toxins, and underlying chronic conditions, can predispose someone to severe pulmonary hypertension.

The World Health Organisation (WHO) classifies the causes of severe pulmonary hypertension into different groups, including:

Group 1: Pulmonary arterial hypertension (PAH)

Causes include:

Group 2: Pulmonary hypertension due to left-sided cardiac disease

Causes are:

  • left-sided valvular heart valve disease, such as aortic or mitral valve disease
  • left ventricular failure
  • other congenital cardiomyopathies
    • Group 3: Pulmonary hypertension due to lung disease

    Examples include:

    Group 4: Pulmonary hypertension due to chronic blood clots

    Group 4 pulmonary hypertension can only occur as a result of a condition called chronic thromboembolic pulmonary hypertension (CTEPH). Chronic blood clots in the lungs cause CTEPH.

    Group 5: Pulmonary hypertension due to other health conditions

    Causes include:

  • blood disorders, such as myeloproliferative disorders
  • inflammatory conditions such as sarcoidosis and vasculitis
  • metabolic disorders, such as glycogen storage diseases.
  • chronic kidney disease
  • mechanical obstruction from tumors compressing the pulmonary arteries

    • Learn more about the five classes of pulmonary hypertension.

    Doctors typically diagnose pulmonary hypertension using a combination of clinical findings and laboratory investigations. During the medical history, the doctor will ask questions about the presenting symptoms and conduct a physical examination.

    The doctor will typically perform a general and chest examination to identify signs of pulmonary hypertension.

    Doctors will conduct the following laboratory tests to diagnose pulmonary hypertension:

  • Cardiac catheterization: This procedure helps to measure the blood pressure in the pulmonary arteries. A doctor will diagnose severe pulmonary hypertension if a person's blood pressure exceeds 70 mmHg.
  • Echocardiography: Doctors use it to evaluate the structure and functions of the heart chambers.

    • Other supportive tests include:

    Learn more about diagnosing pulmonary hypertension.

    The treatment of severe pulmonary hypertension requires a combination of different types of treatments.

    According to the Pulmonary Hypertension Association, therapeutic interventions include:

  • Intravenous medications: Epoprostenol is a vasodilator that relaxes the pulmonary blood vessels and improves blood flow. It is typically the first-line medication for treating severe pulmonary hypertension. Doctors may also use ambrisentan, bosentan, macitentan, riociguat.
  • Oxygen therapy and ventilation support.
  • Lung transplant, especially for those with severe lung damage.
  • Interventional cardiac surgeries
  • Supportive care and other medications, such as diuretics, to reduce fluid retention in the lungs.

    • Treatment for pulmonary hypertension depends on which WHO group the person falls into and the level of their pulmonary blood pressure. For example, someone in WHO Group 1 will undertake a different treatment course than someone from Group 2.

    Learn more about treating pulmonary hypertension.

    Below are some commonly asked questions about severe pulmonary hypertension:

    What are the stages of pulmonary hypertension?

    The four stages of pulmonary hypertension are:

  • Class I: No symptoms during rest or when performing activities.
  • Class II: Presence of symptoms, such as fatigue or shortness of breath, during routine activities, except at rest.
  • Class III: Symptomatic and experiences fatigue, shortness of breath, and chest pain. People may also experience limitations in performing everyday activities.
  • Class IV: Symptoms occur at rest and during any physical activity.
    • What is the life expectancy for severe pulmonary hypertension?

    The life expectancy of severe pulmonary hypertension varies for each person. The following factors can have an impact on someone's life expectancy:

  • what WHO group the pulmonary hypertension falls into — for example, someone in group 1 with idiopathic pulmonary hypertension is likely to have a poor outlook
  • the available treatments
  • the class of symptoms a person has
    • How common is severe pulmonary hypertension?

    Generally, pulmonary hypertension is rare. However, severe pulmonary hypertension tends to be more prevalent in people with COPD.

    Severe pulmonary hypertension is a clinical condition in which the resting blood pressure in the pulmonary arteries is above 70mmHg. Individuals with severe pulmonary hypertension may notice profound shortness of breath, cyanosis, chest pain, intense fatigue, and severe dizziness.

    Genetic factors, chronic medical conditions, and exposure to environmental toxins are possible causes of severe pulmonary hypertension.

    Cardiac catheterization and echocardiography are essential tests for diagnosing severe pulmonary arterial hypertension.

    Severe pulmonary hypertension treatment includes pulmonary vasodilators, oxygen and ventilation support, and lung transplantation.

    Learn more about hypertension in our dedicated hub.


    Pulmonary Hypertension Directory

    Pulmonary hypertension is high blood pressure in the arteries leading from the heart to the lungs. Pulmonary hypertension is a different condition than ordinary high blood pressure (hypertension). Many different conditions can cause pulmonary hypertension, including congestive heart failure, blood clots in the lungs, HIV infection, and more. In most patients, pulmonary hypertension has an identifiable cause. Although there's no cure, treatments can reduce the symptoms of primary pulmonary hypertension, including shortness of breath. Follow the links below to find WebMD's comprehensive coverage about pulmonary hypertension, what it looks like, how to treat it, and much more.

    Medical Reference View AllFeatures News Archive View All

    What Is Cor Pulmonale?

    SOURCES:

    American Heart Association: "How the Healthy Heart Works."

    ‌American Lung Association: "Oxygen Therapy."

    ‌American Thoracic Society: "Obesity Hypoventilation Syndrome."

    ‌Cystic Fibrosis Foundation: "About Cystic Fibrosis."

    ‌Cleveland Clinic: "Interstitial Lung Disease."

    Food and Drug Administration: "Radiography."

    Gopal, S.; Nagalli, S. StatPearls: Jugular Venous Distention. StatPearls Publishing, 2021.

    Heart Failure Reviews: "Cor pulmonale: the role of traditional and advanced echocardiography in the acute and chronic settings."

    Issac, S.; Das, J. StatPearls: Kyphoscoliosis. StatPearls Publishing, 2021.

    Johns Hopkins Medicine: "Cardiac Catheterization."

    Garrison, D.; Satish Pendela V.; Memon, J. StatPearls: Cor Pulmonale. StatPearls Publishing, 2020.

    ‌Mayo Clinic: "COPD," "Edema," "Electrocardiogram (ECG or EKG)," "Obstructive sleep apnea," "Pulmonary hypertension," "Scleroderma."

    Mayo Clinic Proceedings: "Doppler Echocardiography: Theory, Instrumentation, Technique, and Application."

    Merck Manual: "Cor Pulmonale."

    Merriam-Webster: "exertion," "lethargy."‌





    Comments

    Post a Comment

    Popular posts from this blog

    Roseola vs. measles rash: What is the difference? - Medical News Today

    Image
    Roseola and measles are two different diseases that present with a high fever and a rash. They are both most commonly seen in childhood, although measles can affect people of any age, and roseola in adults is very rare. While both diseases share similarities, there are distinguishing factors, such as how the symptoms present and the disease progression. Read on to find out the difference between roseola and measles rashes. Roseola, also known as roseola infantum, sixth disease, or exanthema subitum, is a viral infection that typically affects children. The human herpesvirus 6 (HHV-6) or human herpesvirus 7 (HHV-7) causes roseola. The disease is spread through tiny respiratory droplets that people either breathe in or pick up from surfaces they touch. This disease usually presents in children between the ages of 6–12 months . Children who have this disease experience a high fever, followed by a pink or red rash. Roseola is a self-limiting viral illness, meaning it will typically go awa...
    Read more

    poliomyelitis treatment

    Image
    poliomyelitis treatment Drug and Device News March 2019 - P&T Community Posted: 04 Mar 2019 10:35 AM PST NEW DRUG APPROVALS Ontruzant, a Herceptin Biosimilar The FDA has approved trastuzumabdttb (Ontruzant, Samsung Bioepis Company, Ltd.) for HER2-overexpressing breast cancer and HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma. Trastuzumabdttb, a HER2/neu receptor antagonist, is the third FDA-approved biosimilar of Herceptin (Genentech). Patients should be selected for therapy based on an FDA-approved companion diagnostic. Trastuzumab-dttb carries a boxed warning about the risks of cardiomyopathy, serious and fatal infusion reactions, embryo-fetal toxicity, and pulmonary toxicity. Ontruzant will be marketed and distributed in the U.S. by Merck. Sources: Samsung Bioepis, January 21, 2019; Ontruzant . prescribing information, January 2019; FDA, January 18, 2019 Vaxelis, a Combination Vaccine T...
    Read more

    Coronavirus fake news echoes century-old polio fears - Newsroom

    Image
    Coronavirus fake news echoes century-old polio fears - Newsroom Coronavirus fake news echoes century-old polio fears - Newsroom Posted: 05 Feb 2020 08:32 AM PST FEBRUARY 6, 2020 Updated 15 hours ago Dr Heather Battles Dr Heather Battles is a lecturer in anthropology at the University of Auckland and researches infectious diseases and epidemics. Show more Ideasroom During the past month, in the confusion and uncertainty over the precise origin of the 2019 novel coronavirus outbreak, many alternate ideas or 'conspiracy theories' have sprung up and spread widely via social media including Twitter and Facebook. I have had a sense of déjà vu as many of these claims have parallels in how people responded to another 'emerging' epidemic disease a century ago: polio. The first example that struck me is the idea (spread by US fake news website Infowars and others) that the roll-out of 5G technology is to blame, wit...
    Read more